BioCentury | Oct 6, 2014
Clinical News

Algisyl-LVR regulatory update

...inert polymer is injected into the left ventricle muscle and acts as an internal scaffold. LoneStar Heart Inc....
BioCentury | Mar 6, 2014
Tools & Techniques

Taking TIMP3 to heart

...structure and by dampening the MI-associated inflammation. Data were published in Science Translational Medicine . LoneStar Heart Inc....
...Oaks, Calif. Institut National de la Sante et de la Recherche Medicale , Lille, France LoneStar Heart Inc....
BioCentury | Oct 15, 2012
Company News

LoneStar Heart board of directors update

LoneStar Heart Inc. , Laguna Hills, Calif. Business: Cardiovascular Appointed: Frank Yu, CEO of Themes Investment Partners WIR Staff Cardiovascular...
BioCentury | Oct 15, 2012
Financial News

LoneStar Heart financial update

...Partners, a new investor based in Hong Kong. Existing investor Dinova Venture Partners also participated. LoneStar Heart Inc....
BioCentury | Oct 10, 2012
Top Story

LoneStar announces series B extension

LoneStar Heart Inc. (Laguna Hills, Calif.) secured up to $20 million in an extension of a series B round led by new investor Themes Investment Partners. Existing investor Dinova Venture Partners also participated. LoneStar raised...
BioCentury | Jun 25, 2012
Emerging Company Profile

LoneStar Heart: Straight to the heart

...are palliative and aimed primarily at delaying pathological cardiac remodeling and progression to advanced disease. LoneStar Heart Inc....
...Cardio3 BioSciences S.A. , Mont-Saint-Guibert, Belgium Heart Failure Society of America , St. Paul, Minn. LoneStar Heart Inc....
...Inc. , Ann Arbor, Mich. University of Texas Southwestern Medical Center , Dallas, Texas Sidebars LoneStar Heart Inc....
BioCentury | May 31, 2012
Distillery Techniques

Technology: Drug platforms

...Next steps include optimizing the treatment protocol and determining the mechanisms responsible for the efficacy. LoneStar Heart Inc....
...page 7). SciBX 5(22); doi:10.1038/scibx.2012.586 Published online May 31, 2012 Patent applications filed; licensed to LoneStar Heart...
BioCentury | May 31, 2012
Tools & Techniques

Reprogramming heart failure

...cells, it could avoid the problems associated with transplanting exogenous cells to improve heart function. LoneStar Heart Inc....
...the Department of Molecular Biology at UT Southwestern and cofounder and chief scientific advisor to LoneStar Heart...
...UT Southwestern have separately filed patents to cover the findings described in their respective papers. LoneStar Heart...
BioCentury | Jan 30, 2012
Company News

LoneStar Heart, University of Texas Southwestern Medical Center deal

...left ventricle during surgery that is in Phase I/II testing to treat later stage cardiomyopathy. LoneStar Heart Inc....
Items per page:
1 - 9 of 9
BioCentury | Oct 6, 2014
Clinical News

Algisyl-LVR regulatory update

...inert polymer is injected into the left ventricle muscle and acts as an internal scaffold. LoneStar Heart Inc....
BioCentury | Mar 6, 2014
Tools & Techniques

Taking TIMP3 to heart

...structure and by dampening the MI-associated inflammation. Data were published in Science Translational Medicine . LoneStar Heart Inc....
...Oaks, Calif. Institut National de la Sante et de la Recherche Medicale , Lille, France LoneStar Heart Inc....
BioCentury | Oct 15, 2012
Company News

LoneStar Heart board of directors update

LoneStar Heart Inc. , Laguna Hills, Calif. Business: Cardiovascular Appointed: Frank Yu, CEO of Themes Investment Partners WIR Staff Cardiovascular...
BioCentury | Oct 15, 2012
Financial News

LoneStar Heart financial update

...Partners, a new investor based in Hong Kong. Existing investor Dinova Venture Partners also participated. LoneStar Heart Inc....
BioCentury | Oct 10, 2012
Top Story

LoneStar announces series B extension

LoneStar Heart Inc. (Laguna Hills, Calif.) secured up to $20 million in an extension of a series B round led by new investor Themes Investment Partners. Existing investor Dinova Venture Partners also participated. LoneStar raised...
BioCentury | Jun 25, 2012
Emerging Company Profile

LoneStar Heart: Straight to the heart

...are palliative and aimed primarily at delaying pathological cardiac remodeling and progression to advanced disease. LoneStar Heart Inc....
...Cardio3 BioSciences S.A. , Mont-Saint-Guibert, Belgium Heart Failure Society of America , St. Paul, Minn. LoneStar Heart Inc....
...Inc. , Ann Arbor, Mich. University of Texas Southwestern Medical Center , Dallas, Texas Sidebars LoneStar Heart Inc....
BioCentury | May 31, 2012
Distillery Techniques

Technology: Drug platforms

...Next steps include optimizing the treatment protocol and determining the mechanisms responsible for the efficacy. LoneStar Heart Inc....
...page 7). SciBX 5(22); doi:10.1038/scibx.2012.586 Published online May 31, 2012 Patent applications filed; licensed to LoneStar Heart...
BioCentury | May 31, 2012
Tools & Techniques

Reprogramming heart failure

...cells, it could avoid the problems associated with transplanting exogenous cells to improve heart function. LoneStar Heart Inc....
...the Department of Molecular Biology at UT Southwestern and cofounder and chief scientific advisor to LoneStar Heart...
...UT Southwestern have separately filed patents to cover the findings described in their respective papers. LoneStar Heart...
BioCentury | Jan 30, 2012
Company News

LoneStar Heart, University of Texas Southwestern Medical Center deal

...left ventricle during surgery that is in Phase I/II testing to treat later stage cardiomyopathy. LoneStar Heart Inc....
Items per page:
1 - 9 of 9